Stock Price Quote

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE63.65-0.15 (-0.24 %)
PREV CLOSE ( ) 63.80
OPEN PRICE ( ) 64.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 524634
TODAY'S LOW / HIGH ( )61.45 64.40
52 WK LOW / HIGH ( )38.7 64.9
NSE63.60-0.2 (-0.31 %)
PREV CLOSE( ) 63.80
OPEN PRICE ( ) 63.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 63.60 (2844)
VOLUME 3355631
TODAY'S LOW / HIGH( ) 61.50 64.45
52 WK LOW / HIGH ( )38.6 65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Mark Saldanha - Chairman Mark Saldanha - Managing Director
Registered Office

Address 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W),
Mumbai,
Maharashtra-400053

Phone 022- 40012000

Email info@marksanspharma.com

Website www.marksanspharma.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

02Nov Marksans Pharma informs about daily re
With reference to the Buyback of equity shares of Re 1 each of the compa..
25Oct Marksans Pharma informs about buyback
Marksans Pharma has informed that it submitted the daily report pursuant..
12Oct Marksans Pharma shines on entering int
Marksans Pharma is currently trading at Rs. 48.95, up by 2.30 points or..
12Oct D B Realty, Marksans Pharma and Genesy
D B Realty has acquired entire equity shares of Spacecon Realty (Spaceco..
11Oct Marksans Pharma enters into Business T
Marksans Pharma has entered into a Business Transfer Agreement with Teva..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit402.291039.88
Gross Profit 489.84 1345.08
Operating Profit 548.051559.66
Net Sales 1702.596582.89

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4159.50 (1.65%)
M.Cap ( in Cr)6904.51
RPG Life Sciences (BSE)
peergroup  912.65 (4.85%)
M.Cap ( in Cr)1509.43
Samrat Pharmachem (BSE)
peergroup  827.45 (5.00%)
M.Cap ( in Cr)255.66
Hikal (BSE)
peergroup  384.85 (9.63%)
M.Cap ( in Cr)4745.23
Glaxosmithkline Phar (BSE)
peergroup  1339.45 (0.85%)
M.Cap ( in Cr)22691.09

Shareholding Pattern

PROMOTERS 48.6%
NON-INSTITUTION 46.38%
MUTUAL FUNDS/UTI 0.95%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

About Marksans Pharma Ltd.

Marksans Pharma Ltd. was incorporated in the year 1992. Its today's share price is 63.65. Its current market capitalisation stands at Rs 2565.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6653.02 Cr and Total Income of Rs.7005.4 Cr. The company's management includes Harshavardhan Panigrahi, Sunny Sharma, Meena Surana, Abhinna Sundar Mohanty, Digant Mahesh Parikh, Seetharama Raju Buddharaju, Varddhman Vikramaditya Jain, Sandra Saldanha, Mark Saldanha, Mark Saldanha.

It is listed on the BSE with a BSE Code of 524404 , NSE with an NSE Symbol of MARKSANS and ISIN of INE750C01026. It's Registered office is at 11th Floor, " Grandeur ",Opp. Gundecha Symphony, Veera Desai Extension Road,Oshiwara, Andheri (W)Mumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bhuta Shah & Co LLP, NK Mittal & Associates, VS Lalpuria & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)